NKGNW logo

NKGen Biotech Warrants (NKGNW) Financials

Balance sheets

30 June 202431 Mar 202431 Dec 202330 Sept 202330 June 202331 Dec 202230 Sept 2022

Total Assets

$15.6 M(-4.1%)$16.3 M(-1.0%)$16.5 M(-34.6%)$25.2 M-$16.3 M-

Current Assets

$1.2 M(-22.3%)$1.6 M(-16.7%)$1.9 M(-81.3%)$10.3 M-$350.0 K-

Non Current Assets

$14.4 M(-2.1%)$14.7 M(+1.1%)$14.6 M(-2.0%)$14.8 M-$16.0 M-

Total Liabilities

$85.4 M(+19.6%)$71.4 M(-5.1%)$75.2 M(+14.2%)$65.8 M-$14.8 M-

Current Liabilities

$51.4 M(+37.1%)$37.5 M(-5.0%)$39.5 M(+1.6%)$38.8 M-$14.7 M-

Long Term Liabilities

$34.0 M(+0.2%)$33.9 M(-5.1%)$35.7 M(+32.4%)$27.0 M-$26.0 K-

Shareholders Equity

-$69.7 M(-26.6%)-$55.1 M(+6.2%)-$58.7 M(-44.4%)-$40.6 M-$1.6 M-

Book Value

-$69.8 M(-26.6%)-$55.1 M(+6.2%)-$58.8 M(-44.3%)-$40.7 M-$1.5 M-

Working Capital

-$50.2 M(-39.8%)-$35.9 M(+4.4%)-$37.5 M(-31.7%)-$28.5 M--$14.4 M-

Cash And Cash Equivalents

$79.0 K(+132.3%)$34.0 K(+30.8%)$26.0 K(-99.7%)$8.8 M-$117.0 K-

Accounts Payable

$12.7 M(-1.1%)$12.8 M(+16.3%)$11.0 M(+39.1%)$7.9 M-$1.0 M-

Accounts Receivable

--$0.0(0%)$0.0-$29.0 K-

Short Term Debt

$17.3 M(+49.4%)$11.6 M(+15.8%)$10.0 M(+91.0%)$5.2 M-$11.7 M-

Long Term Debt

$10.7 M(+1.8%)$10.5 M(+5.7%)$9.9 M(-32.5%)$14.7 M-$0.0-

Total Debt

$28.1 M(+26.6%)$22.2 M(+11.5%)$19.9 M(-0.6%)$20.0 M-$12.0 M-

Debt To Equity

-0.4(0%)-0.4(-17.6%)-0.3(+30.6%)-0.5-7.7-

Current Ratio

0.0(-50.0%)0.0(-20.0%)0.1(-81.5%)0.3-0.0-

Quick Ratio

-------

Inventory

-------

Retained Earnings

-$183.6 M(-9.6%)-$167.5 M(-3.3%)-$162.1 M(-26.1%)-$128.5 M--$79.2 M-

PB Ratio

-------

Income statements

30 June 202431 Mar 202431 Dec 202330 Sept 202330 June 202331 Dec 202230 Sept 2022

EPS

-------

TTM EPS

-------

Revenue

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(-100.0%)$3000.0

TTM Revenue

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(-100.0%)$3000.0(0%)$3000.0(0%)$3000.0

Total Expenses

$7.5 M(-2.1%)$7.6 M(-19.2%)$9.4 M(+36.6%)$6.9 M(+4.4%)$6.6 M(+5.6%)$6.3 M(+4.4%)$6.0 M

Operating Expenses

$7.5 M(-2.1%)$7.6 M(-19.2%)$9.4 M(+36.6%)$6.9 M(+4.4%)$6.6 M(+5.9%)$6.2 M(+4.2%)$6.0 M

Cost Of Goods Sold

--$0.0(0%)$0.0-$15.0 K(+100.0%)$0.0

TTM Cost Of Goods Sold

--$0.0(-100.0%)$15.0 K-$15.0 K(+100.0%)$0.0

Gross Profit

--$0.0(0%)$0.0--$15.0 K(-600.0%)$3000.0

TTM Gross Profit

--$0.0(+100.0%)-$15.0 K--$12.0 K(-500.0%)$3000.0

Gross Margin

------100.0%

Operating Profit

-$7.5 M(+2.1%)-$7.6 M(+19.2%)-$9.4 M(-36.6%)-$6.9 M(-4.4%)-$6.6 M(-5.6%)-$6.3 M(-4.5%)-$6.0 M

TTM Operating Profit

-$31.4 M(-2.8%)-$30.6 M(-33.2%)-$22.9 M(-16.0%)-$19.8 M(-4.8%)-$18.9 M(-54.0%)-$12.3 M(-104.5%)-$6.0 M

Operating Margin

-------199.7 K%

Net Income

-$16.1 M(-198.9%)-$5.4 M(+84.0%)-$33.6 M(-1.3%)-$33.2 M(-322.7%)-$7.8 M(-13.0%)-$6.9 M(-3.8%)-$6.7 M

TTM Net Income

-$88.3 M(-10.3%)-$80.0 M(-7.2%)-$74.6 M(-55.6%)-$48.0 M(-123.2%)-$21.5 M(-57.5%)-$13.6 M(-103.8%)-$6.7 M

Net Margin

-------

EBIT

-$15.4 M(-258.0%)-$4.3 M(+87.0%)-$33.2 M(-0.6%)-$33.0 M(-323.4%)-$7.8 M(-23.1%)-$6.3 M(-4.4%)-$6.1 M

TTM EBIT

-$85.9 M(-9.8%)-$78.2 M(-5.8%)-$73.9 M(-57.0%)-$47.1 M(-133.4%)-$20.2 M(-62.9%)-$12.4 M(-104.4%)-$6.1 M

EBITDA

-$7.1 M(+16.3%)-$8.5 M(+6.7%)-$9.1 M(-87.8%)-$4.9 M(+21.6%)-$6.2 M(-11.2%)-$5.6 M(+6.8%)-$6.0 M

TTM EBITDA

-$29.6 M(-3.2%)-$28.7 M(-42.2%)-$20.2 M(-21.3%)-$16.6 M(+6.3%)-$17.8 M(-53.7%)-$11.6 M(-93.2%)-$6.0 M

Selling, General & Administrative Expenses

$4.4 M(-0.3%)$4.4 M(-17.9%)$5.3 M(+79.6%)$3.0 M(+16.1%)$2.6 M(+18.7%)$2.2 M(+15.2%)$1.9 M

TTM SG&A

$17.1 M(+11.8%)$15.3 M(+40.3%)$10.9 M(+41.4%)$7.7 M(+16.7%)$6.6 M(+63.5%)$4.0 M(+115.2%)$1.9 M

Depreciation And Amortization

$326.0 K(0%)$326.0 K(+8.7%)$300.0 K(0%)$300.0 K(+0.3%)$299.0 K(-59.9%)$746.0 K-

TTM D&A

$1.3 M(+2.2%)$1.2 M(+36.3%)$899.0 K(-33.2%)$1.3 M(+28.7%)$1.0 M(+40.1%)$746.0 K-

Interest Expense

$647.0 K(-39.5%)$1.1 M(+144.1%)$438.0 K(+107.6%)$211.0 K(+240.3%)$62.0 K(-89.9%)$616.0 K(-3.1%)$636.0 K

TTM Interest Expense

$2.4 M(+32.9%)$1.8 M(+150.3%)$711.0 K(-20.0%)$889.0 K(-32.3%)$1.3 M(+5.0%)$1.3 M(+96.9%)$636.0 K

Income Tax

$0.0-$7000.0(+100.0%)$0.0(0%)$0.0(-100.0%)$7000.0(+100.0%)$0.0

TTM Income Tax

$7000.0-$7000.0(0%)$7000.0(0%)$7000.0(0%)$7000.0(+100.0%)$0.0

PE Ratio

-------

PS Ratio

-------

Cashflow statements

30 June 202431 Mar 202431 Dec 202330 Sept 202330 June 202331 Dec 202230 Sept 2022

Cash From Operations

-$6.0 M(-48.7%)-$4.0 M(+41.9%)-$6.9 M(-52.0%)-$4.6 M(+17.4%)-$5.5 M(-1.2%)-$5.5 M-

TTM CFO

-$21.5 M(-2.2%)-$21.1 M(-23.7%)-$17.0 M(-9.5%)-$15.6 M(-41.5%)-$11.0 M(-101.2%)-$5.5 M-

Cash From Investing

-$15.0 K(-142.9%)$35.0 K(+294.4%)-$18.0 K(-100.0%)$0.0(+100.0%)-$17.0 K(-240.0%)-$5000.0-

TTM CFI

$2000.0(+100.0%)$0.0(+100.0%)-$35.0 K(-59.1%)-$22.0 K(0%)-$22.0 K(-340.0%)-$5000.0-

Cash From Financing

$6.1 M(+51.2%)$4.0 M(+322.2%)-$1.8 M(-114.9%)$12.1 M(+93.4%)$6.3 M(+14.0%)$5.5 M-

TTM CFF

$20.4 M(-1.0%)$20.6 M(+24.1%)$16.6 M(-30.6%)$23.9 M(+103.0%)$11.8 M(+114.0%)$5.5 M-

Free Cash Flow

-$6.0 M(-49.1%)-$4.0 M(+42.0%)-$7.0 M(-52.4%)-$4.6 M(+17.7%)-$5.5 M(-1.4%)-$5.5 M-

TTM FCF

-$21.6 M(-2.2%)-$21.1 M(-23.6%)-$17.1 M(-9.5%)-$15.6 M(-41.4%)-$11.0 M(-101.4%)-$5.5 M-

CAPEX

--$18.0 K-$17.0 K(+240.0%)$5000.0-

TTM CAPEX

--$35.0 K-$22.0 K(+340.0%)$5000.0-

Dividends Paid

-------

TTM Dividends Paid

-------

TTM Dividend Per Share

-------

TTM Dividend Yield

-------

Payout Ratio

-------